BRNS vs SQ
Barinthus Biotherapeutics plc (BRNS) versus SQ (SQ) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
SQ (SQ) common stock.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
SQ does not have a complete income-statement cache yet.
BRNS currently screens at market cap $38.2M.
Not investment advice. Open the BRNS and SQ stock pages for the full models.
Not investment advice.